Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adelaide A Hebert

Showing results (111-120 of 150) with videos related to

Pageof 15
Sort By:
Pediatric Dermatology|December 21, 2021
Higher rates of skin clearance and efficacy in challenging body areas are associated with better health-related quality of life following ixekizumab maintenance treatment in pediatric patients with plaque psoriasisAdelaide A Hebert, Margaret A Bobonich, Claudia Rodriguez Capriles, et al.
JAMA Dermatology|July 17, 2014
Dermatologic and dental aspects of the 2012 International Tuberous Sclerosis Complex Consensus StatementsJoyce M C Teng, Edward W Cowen, Mari Wataya-Kaneda, et al.
Journal of Drugs in Dermatology : JDD|March 5, 2024
Early and Sustained Acne Lesion Reductions With Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% GelJulie C Harper, Leon H Kircik, Michael Gold, et al.
The Journal of Dermatological Treatment|August 30, 2008
Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adultsWilliam Abramovits, Adelaide A Hebert, Mark Boguniewicz, et al.
Journal of Drugs in Dermatology : JDD|February 5, 2026
Efficacy and Safety of Clascoterone Cream 1% for Acne Are Independent of Age and SexJames Libecco, Lawrence F Eichenfield, Adelaide A Hebert, et al.
Journal of Drugs in Dermatology : JDD|June 4, 2025
Practical Algorithm on Topical Treatment of Flaring Atopic Dermatitis (AD) With or Without Secondary InfectionLawrence A Schachner, Adelaide A Hebert, Robert Sidbury, et al.
Drugs in R&D|October 5, 2018
Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm TrialJohn M Slopis, Octavio Arevalo, Cynthia S Bell, et al.
Pediatric Dermatology|July 17, 2023
Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double-blind, placebo-controlled trialMaria Hordinsky, Adelaide A Hebert, Melinda Gooderham, et al.
The New England Journal of Medicine|January 18, 2008
Etanercept treatment for children and adolescents with plaque psoriasisAmy S Paller, Elaine C Siegfried, Richard G Langley, et al.
Journal of the American Academy of Dermatology|August 22, 2017
Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitisLawrence F Eichenfield, Robert S Call, Douglass W Forsha, et al.
Pageof 15

Showing results (111-120 of 150) with videos related to

Sort By:
Pageof 15
Pediatric Dermatology|December 21, 2021
Higher rates of skin clearance and efficacy in challenging body areas are associated with better health-related quality of life following ixekizumab maintenance treatment in pediatric patients with plaque psoriasisAdelaide A Hebert, Margaret A Bobonich, Claudia Rodriguez Capriles, et al.
JAMA Dermatology|July 17, 2014
Dermatologic and dental aspects of the 2012 International Tuberous Sclerosis Complex Consensus StatementsJoyce M C Teng, Edward W Cowen, Mari Wataya-Kaneda, et al.
Journal of Drugs in Dermatology : JDD|March 5, 2024
Early and Sustained Acne Lesion Reductions With Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% GelJulie C Harper, Leon H Kircik, Michael Gold, et al.
The Journal of Dermatological Treatment|August 30, 2008
Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adultsWilliam Abramovits, Adelaide A Hebert, Mark Boguniewicz, et al.
Journal of Drugs in Dermatology : JDD|February 5, 2026
Efficacy and Safety of Clascoterone Cream 1% for Acne Are Independent of Age and SexJames Libecco, Lawrence F Eichenfield, Adelaide A Hebert, et al.
Journal of Drugs in Dermatology : JDD|June 4, 2025
Practical Algorithm on Topical Treatment of Flaring Atopic Dermatitis (AD) With or Without Secondary InfectionLawrence A Schachner, Adelaide A Hebert, Robert Sidbury, et al.
Drugs in R&D|October 5, 2018
Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm TrialJohn M Slopis, Octavio Arevalo, Cynthia S Bell, et al.
Pediatric Dermatology|July 17, 2023
Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double-blind, placebo-controlled trialMaria Hordinsky, Adelaide A Hebert, Melinda Gooderham, et al.
The New England Journal of Medicine|January 18, 2008
Etanercept treatment for children and adolescents with plaque psoriasisAmy S Paller, Elaine C Siegfried, Richard G Langley, et al.
Journal of the American Academy of Dermatology|August 22, 2017
Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitisLawrence F Eichenfield, Robert S Call, Douglass W Forsha, et al.
Pageof 15